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Aim To develop and test a protocol for isolation of poten-
tial auto-antigens from chorionic tissue that may be linked 
to recurrent miscarriage (RM).
Methods The strategy included: 1) isolation of IgGs tight-
ly bound to chorionic tissue of RM patients by protein G 
chromatography; 2) construction of affinity columns using 
the chorionic antibodies for isolation of auto-antigens; 3) 
enrichment of auto-antigens from detergent extracted so-
lution of chorionic proteins by affinity chromatography; 4) 
separation by dodecyl sulfate-electrophoresis followed by 
matrix-assisted laser desorption/ionization-time of flight 
mass spectrometry identification.
Results Five potential auto-antigens were detected: neu-
tral alpha-glucosidase AB, endoplasmin, transitional endo-
plasmic reticulum ATPase, putative endoplasmin-like pro-
tein, and cytoplasmic actin 2.
Conclusions We developed a strategy for identification of 
auto-antigens in the chorionic tissue of women with RM, 
which could be of diagnostic and prognostic value.
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Recurrent miscarriage (RM) is a spontaneous loss of three or 
more consecutive pregnancies with the same biological fa-
ther during the first trimester of pregnancy. It affects 1%-2% 
of women and at least one half of the cases have no etiology 
(1,2). Overall, 75% of the affected women can be expected 
to have an unsuccessful subsequent pregnancy, although 
this rate falls in older women and women with an increas-
ing number of miscarriages. A pivotal feature of RM is the 
response of auto-antibodies to different auto-antigens (3). 
Auto-antibodies toward laminin-1 (4) and GalNAcβ determi-
nant of glycans have been detected in women with RM (5). 
Anti-phospholipid syndrome with anti-cardiolipin or lupus 
anticoagulant antibodies is present in 15% of women with 
the recurrent first and second trimester miscarriage (2,6). 
Sinсе the mаternаl immune response toward the fetus is as-
sociated with secondary infertility, it is important to search 
for novel auto-antigens that could contribute to the recur-
rent pregnancy losses. Although auto-antibodies have been 
proposed as an etiology of RM (2,5), the mechanisms leading 
to antibody development and targets of these auto-antibod-
ies are poorly understood. Recently, we have detected high-
er levels of IgGs tightly bound to chorionic tissue of RM pa-
tients in comparison to findings from the embryonic kidney, 
lung, heart, intestine, and skin of a spontaneously aborted 
fetus due to other etiology (7). Thus, we investigated wheth-
er auto-antibodies possessing specificity to chorionic tissue 
proteins could allow detection of potential auto-antigens in-
volved in the development of RM. The aim of this study was 
to develop an approach for detection and identification of 
auto-antigens in chorionic tissue of women with RM.
MateRiaL anD MethoDS
Patients
Chorionic tissue of 8 women (21-33 years old) with the history 
of spontaneous abortion (2 of them with 2 delivery losses and 
6 with 3 consecutive miscarriages) with first trimester ges-
tational age and blighted ovum were included in the study 
conducted during 2012 at the Institute of Hereditary Pathol-
ogy, NAMS of Ukraine. Tissue was stored at -70°C. Blood serum 
of 3 women (27, 29, 33 years old) without obstetric and ge-
netic history of diseases who had at least two healthy children 
was used as a control. The biological samples were collected 
and studied under the control of the Ethics Committee of the 
Institute of Hereditary Pathology, NAMS of Ukraine.
auto-antibodies purification
Samples were collected and carefully washed with 
phosphate buffered saline (PBS, pH 7.4) and homog-
enized in the Tris buffered saline (TBS, 20 mM Tris-HCl, pH 
7.4) containing 1% Triton-X100 (TBS-T) in the presence of 
a mixture of protease inhibitors (Sigma-Aldrich, St. Louis, 
MO, USA). All steps were carried out at 4°C. The homoge-
nates were incubated for 30 minutes at 4°C and centri-
fuged at 30 000 g, 4°C. Supernatants from those homo-
genates were loaded onto Protein G-Sepharose column 
(Sigma), sequentially washed with TBS-T, and then washed 
with TBS. ABs were eluted from the column with 0.1 M Gly-
HCl buffer, pH 2.3, and immediately neutralized with 1.5 M 
Tris-HCl, pH 8.8. Protein concentration was measured by 
using the NanoDrop ND 1000 spectrophotometer (Nano-
Drop Technologies, Wilmington, DE, USA). Abs were bioty-
nilated or used for preparation of the affinity matrix. As a 
control affinity matrix, IgGs purified from blood serum ob-
tained from 3 healthy women by chromatography on Pro-
tein G-Sepharose column was used.
Dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PaGe) and Western blot analysis
SDS electrophoresis of proteins was performed in 12% 
polyacrylamide as described previously (8). Proteins were 
electrically transferred onto nitrocellulose membrane, 
which was blocked by 5% non-fat milk in the PBS contain-
ing 0.05% Tween-20 at 20°C, 1 hour. In order to detect au-
to-antibodies in the chorionic detergent extracts, the blots 
were washed with PBS-Tween-20 three times for 5 minutes 
each, and then probed with secondary antibodies cova-
lently bound to horseradish peroxidase (Sigma) dissolved 
in 5% non-fat milk/PBS-Tween-20 blocking solution. After 
incubation, the membrane was washed three times for 5 
minutes in the PBS-Tween-20 and proteins were visual-
ized by the ECL Western blotting detection reagents (Am-
ersham, Little Chalfont, UK). To detect the auto-antibodies 
binding to chorionic proteins, they were first biotinylated 
according to the manufacturer’s protocol using hydrazine-
biotin reagent (Sigma). The blots were incubated overnight 
at 4°С with biotinylated auto-antibodies (50 μg/mL). The 
membrane was incubated in the Avidin-HRP conjugates 
(Sigma), dissolved in 5% non-fat milk/PBS-Tween-20 block-
ing solution, and processed as described above.
Preparation of the auto-antigens binding Sepharose 
(auto-antibodies Sepharose).
IgGs obtained from the chorionic tissue and IgGs obtained 
from blood serum of healthy donors were immobilized on 
the HC-Sepharose 4B (Sigma) according to the manufac-
turer’s protocol.
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Purification of auto-antigens
In order to purify the auto-antigens, Triton Х-100 extract-
ed-proteins from the chorionic tissue of the RM patients 
were subjected to the affinity chromatography on the 
auto-antibodies Sepharose column. Protein extracts (3 
mL, 6.3 mg/mL) were incubated with 1 mL of the auto-
antibodies-matrix for 1 hour at 24°C in the TBS containing 
a mixture of protease inhibitors. After incubation, the au-
to-antibodies Sepharose were loaded onto a column and 
washed once in the TBS supplemented with 0.05% Twin 
20 and three times with the TBS. As a control, Triton X-100-
extracted proteins were subjected to chromatography on 
a column with Sepharose conjugated with IgG isolated 
from the blood serum of healthy human donors. Proteins 
were eluted from the affinity column with 0.1 M Gly-HCl 
buffer, pH 2.3, neutralized with 1.5 M Tris-HCl, pH 8.8, and 
separated by the SDS-PAGE electrophoresis in PAG gradi-
ent (7%-16.5%). Proteins on gels were stained with Coo-
massie G-250, and the appropriate protein bands were ex-
cised from gels, and used for protein identification by the 
matrix-assisted laser desorption/ionization-time of flight 
mass spectrometry (MALDI-TOF).
MaLDi-toF analysis
Following electrophoresis, individual bands from the PAG 
were excised and treated by in-gel trypsin digestion. Af-
ter proteolysis and extraction of the generated peptides, 
the mixture was analyzed using a 4800 MALDI-TOF/TOF 
mass spectrometer (AB Sciex, Foster City, CA, USA). Both 
tandem mass spectrometry (MS and MS/MS) spectra were 
searched in a combined search in GPS Explorer (AB Sciex, 
Framingham, MA, USA) using MASCOT engine (Matrix Sci-
ence, London, UK) against human protein database down-
loaded from Universal Protein Resource (UniProt, www.uni-
prot.org).
ReSuLtS
We developed an approach to detect and identify poten-
tial auto-antigens that could be involved in the RM devel-
opment (Figure 1). SDS-PAGE analysis of proteins of the 
chorionic tissue followed by their transfer to nitrocellulose 
membrane and probing with anti-human IgGs revealed 
heavy and light chains of human IgG in the lysates of the 
chorionic tissue (Figure 2). In order to isolate auto-antibod-
ies from the chorionic tissue, its lysate was subjected to the 
affinity chromatography on the Protein G-Sepharose col-
umn. The IgGs fraction was eluted with acidic (pH 2.3) buf-
fer allowing dissociation of various tightly bound immune 
complexes. A portion of the affinity isolated IgGs was used 
for biotinylation followed by western-blot analysis, while 
the remainder of the IgG fraction was coupled to Sephar-
ose-matrix and used as an auto-antibodies bearing affin-
FiGuRe 1. Scheme of affinity purification of the potential 
auto-antigens from chorionic tissue of recurrent miscarriage 
patients.
FiGuRe 2. Determination of the presence of igGs in typical 
preparations of triton X-100 extracted chorionic proteins by 
Western-blot analysis. the membrane was stained with Ponco 
C (lanes 1, 2, 3) and after washing was treated with mono spe-
cific horseradish peroxidase -conjugated rabbit anti-human 
igGs (lanes 1’, 2’, 3′). auto-antibodies presence was tested as 
described in Material and Methods.
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ity sorbent. Before the affinity chromatography, the auto-
antibodies were first assayed for their capacity to bind the 
chorionic tissue auto-antigens. Binding of the biotinylated 
auto-antibodies was compared with the binding of con-
trol biotinylated IgGs purified from blood serum of healthy 
human donors. The biotinylated antibodies eluted from 
chorionic tissue bound different proteins separated by the 
SDS-PAGE electrophoresis (Figure 3, lanes 1, 2). The biotiny-
lated IgGs from blood serum of healthy donors, as well as 
the avidin-horseradish peroxidase conjugates bound only 
polypeptides migrating in the range of 67 kDa (Figure 3, 
lanes 3-6), while the biotinylated IgGs isolated from blood 
serum of RM women recognized a distinct set of chori-
onic proteins (Figure 4), which were subsequently identi-
fied by the MALDI-TOF MS as neutral alpha-glucosidase AB 
(107 kDa, Acc: ENPL_HUMAN), endoplasmin (92 kDa, Acc: 
GANAB_HUMAN), transitional endoplasmic reticulum AT-
Pase (89 kDa, Acc: TERA_HUMAN), putative endoplasmin-
like proteins (46 kDa, Acc: ENPLL_HUMAN), and cytoplas-
mic actin 2 (42 kDa, Acc: ACTG_HUMAN).
DiSCuSSion
In this report, we described an approach that can be used 
for identification of the auto-antigens of chorionic tissue 
obtained from women with the RM. Application of this 
approach allowed us to identify 5 novel potential auto-
antigens that could be associated with RM. Spontaneous 
pregnancy loss has been defined as 3 consecutive preg-
nancy losses prior to 20 weeks from the last menstru-
al period (2). However, there are no reliable data on the 
probability of RM in the population with 2 or 3 and more 
miscarriages, since the available data suggest that after 2 
losses the risk of miscarriage in subsequent pregnancies is 
30%, compared with 33% after 3 losses, which is not a big 
difference among patients without a history of a live birth 
(9). This strongly suggests the importance of evaluating 
patients with 2 losses, such patients insist on their further 
clinical investigation. This is why we included in our study 
women with both 2 (2 patients) and 3 (6 patients) deliv-
ery losses.
Among 5 novel potential auto-antigens that we found to 
be associated with the RM, there is a neutral alpha-glucosi-
dase AB. This enzyme [EC 3.2.1.84] is encoded in humans 
by the GANAB gene (10), and is located in the endoplas-
mic reticulum. It catalyzes the hydrolysis of the inner two 
α1,3-linked glucose residues present in all N-linked imma-
FiGuRe 3. Western-blot analysis of typical preparations of 
triton X-100 extracted chorionic proteins using biotinylated 
auto-igGs isolated from chorionic tissues (lane 1, 2). as control 
we used igGs isolated from blood serum of healthy donors 
(lanes 3,4) or avidine-hRP reagent.
FiGuRe 4. Dodecyl sulfate-electrophoresis in gradient of the 
polyacrylamide gel (7%-16%) in reducing condition of poly-
peptides isolated from chorionic extracts by affinity chroma-
tography on auto-antibodies Sepharose column (lane 1) and 
igG-antibodies healthy humans bearing Sepharose column 
(lane 2, control). M – the standards of molecular mass of 
proteins. on the left, polypeptides applied for matrix-assisted 
laser desorption/ionization mass spectrometry are shown.
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ture oligosaccharides. Another detected auto-antigen is a 
transitional endoplasmic reticulum ATPase [EC 3.6.4.6], also 
known as valosin-containing protein (VCP); it is an enzyme 
that is encoded in humans by the VCP gene (11). It par-
ticipates in fragmentation of the Golgi stacks during mito-
sis and is necessary for their re-assembly after mitosis. It is 
also involved in the formation of the transitional endoplas-
mic reticulum. Our attempts to find in available databases 
the linkage between an appearance of autoantibodies to 
these enzymes and specific human autoimmune diseases 
or reproductive dysfunctions in women have failed. A link 
between actin autoantibodies and autoimmune diseases 
is well known, and it was found in patients with autoim-
mune liver diseases (12,13), celiac disease (14), and rheu-
matoid arthritis (15). The endoplasmin also known as Heat 
Shock Protein 90 kDa Beta Member 1 may participate in 
immune response in RM patients. Endoplasmin is an abun-
dant molecular chaperone resident in the endoplasmic 
reticulum, and it plays a critical role in protein folding in 
the secretory pathway of Toll-like receptors and integrins 
(16,17). It has also been found to be an essential immune 
chaperone involved in regulation of both innate and adap-
tive immunity (18,19). Interestingly, HSP90B1 can serve as 
an endogenous activator for the dendritic cells. Besides, 
there are data that anti-HSP90B1 auto-antibodies could be 
directly engaged in reproductive dysfunction in women 
(20,21). Further studies are needed to investigate whether 
the appearance of anti-HSP90B1 auto-antibodies in blood 
serum of RM patients is linked to the overexpression of this 
stress-responsive protein in human chorionic tissues.
The application of the protocol described in our study al-
lowed identification of potential auto-antigens in the cho-
rionic tissue of women with RM. We hypothesize that the 
identified auto-antigens in chorionic tissue and the rel-
evant auto-antibodies of blood serum contribute to RM, 
and thus could have diagnostic and prognostic value.
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